The "research use only" vial of injectable product was labelled as containing "retatrutide 10mg", an experimental weight loss medication
However, their popularity has rapidly spread to individuals without obesity or metabolic disorders, who use them off-label to achieve or maintain slimness
This category includes medications such as semaglutide, which is used in different forms for type 2 diabetes, chronic weight management, and certain cardiometabolic risk indications depending on the specific medication and patient profile
However, because the program may include fewer touchpoints or opportunities for follow-up, some users may prefer a model that offers closer clinical oversight
Examples include polyethylene glycol (Miralax) and magnesium hydroxide (Milk of Magnesia)
Rocca and Brubaker, 1999)